Allergan (AGN) Removed From Citi's US Focus List

April 21, 2017 6:31 AM EDT Send to a Friend
Citi maintains Buy on Allergen (NYSE: AGN).Analyst Liav Abraham continues to see upside in the stock which should ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login